Our main findings are that serum AIM2 levels are independently related to hemorrhage severity, DCI and 90-day functional outcome after aSAH; moreover, serum AIM2 exhibits significantly effective predictive ability for DCI and poor prognosis at 90 days following aSAH. The gene discussed is AIM2; the disease is hemorrhage.